The non-canonical NF-κB signalling cascade is essential for lymphoid organogenesis, B cell maturation, osteoclast differentiation, and inflammation in mammals 1,2 ; dysfunction of this system is associated with human diseases, including immunological disorders and cancer [3][4] [5] [6] . Although expression of NF-κB-inducing kinase (NIK, also known as MAP3K14) is the rate-limiting step in non-canonical NF-κB pathway activation Our investigation into mechanisms of cell-autonomous immunity revealed that the sine oculis (SO) homeobox family members SIX1 and SIX2 are integral components of the non-canonical NF-κB signalling cascade. In brief, we found that long-term exposure of U-2 OS human osteosarcoma cells with CD40 ligand (TNFSF5) 8 restricted infection by two evolutionarily diverse intracellular pathogens, Gram-positive Listeria monocytogenes and Gram-negative Shigella flexneri (Fig. 1a, b) . This cell-autonomous immune mechanism was dependent on signalling through the non-canonical NF-κB kinase NIK, but not the canonical NF-κB kinase TAK1 (also known as MAP3K7) (Extended Data Fig. 1a-g ). In addition, ectopic expression of NIK, but not TAK1, potently inhibited bacterial infection (Fig. 1c, Extended Data Fig. 1h-j) .
. Data are mean ± s.d. from six independent experiments; ****P < 0.0001 derived from biological replicates using one-way ANOVA (GraphPad). The same statistics were applied to later studies unless otherwise stated. c, Fibroblasts transduced with Fluc or NIK lentivirus and then infected with GFP-expressing L. monocytogenes or S. flexneri as indicated. Quantification of infection is presented as in b. Data are mean ± s.d. from six independent experiments, ****P < 0.0001. Representative flow cytometry scatter plots show infection efficiency as in a. d, Repeated trials of NIK-stimulated genes that inhibit (green) or enhance (red) infection by bacterial pathogens (L. monocytogenes or S. flexneri), positive single-stranded RNA viral pathogens (EAV, equine arteritis virus; WNV, West Nile virus; SINV, Sindbis virus), and negative single-stranded RNA viral pathogen (PIV3, parainfluenza virus type 3). The relative percentage of pathogen infection was normalized to Fluc control (black dotted line). Data are presented as box and whisker plots; box shows 25th and 75th percentiles, black line shows population median, whiskers show highest and lowest values (six independent experiments). *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001; NS, no significant difference. e, Representative flow cytometry scatter plots showing L. monocytogenes infection efficiency in Fluc and SIX2 expressed fibroblasts as described in a. Data are representative of 6 independent experiments. , suggesting that activation of the non-canonical NF-κB signalling pathway is broadly antimicrobial.
To identify key genetic factors involved in the antimicrobial response to activation of non-canonical NF-κB, we generated a cDNA library encompassing 237 genes that were induced by ectopic expression of NIK (mimicking the antimicrobial conditions in Fig. 1c ). We evaluated the rates of bacterial and viral infection in host cells transduced with each of the 237 NIK-stimulated genes in a one-gene to one-well format (Extended Data Fig. 2 , Supplementary Tables 1, 2). A subset of NIK-stimulated genes reproducibly inhibited either bacterial or viral infection, including components of the non-canonical NF-κB signalling cascade (for example, CD40, MAP3K8, and RELB) and antiviral effectors (for example, IRF1, OAS2, and IFI6) (Fig. 1d ). However, two homologous genes-SIX1 and SIX2-specifically caught our attention because, although these genes were activated by NIK, they induced an opposite phenotype to those induced by other NIK-stimulated genes, in that they potently enhanced bacterial and viral infection of host cells (Fig. 1d, e) .
SIX1 and SIX2 are lineage-specific transcription factors that define progenitor cell identity in developing organs and are thought to be silenced in adult tissues 10, 11 . We investigated whether endogenous SIX proteins are reactivated in terminally differentiated immune cells under conditions of physiological infection. Infection of mouse primary bone-marrow-derived macrophages (BMDMs) with L. monocytogenes stimulated transcription of Six1 (roughly twofold) and late-phase accumulation of SIX1 protein (Fig. 2a-c) . Notably, protein expression of SIX1, but not mRNA induction, was potently suppressed in infected BMDMs isolated from Nik −/− mice (Map3k14 gene knockout; Fig. 2a , c, Extended Data Fig. 3a) . De novo synthesis of SIX proteins was also observed in human fibroblasts stimulated with two distinct noncanonical NF-κB agonists: TWEAK, a TNF-family cytokine that signals through the FN14 receptor 12 , and BV6, a SMAC-mimetic compound that promotes rapid NIK protein accumulation by inhibiting cIAP1 and cIAP2 13, 14 ( Fig. 2d, e) . Notably, NIK −/− fibroblasts failed to express SIX proteins under these conditions. Finally, we found that long-lasting treatment (24 h) of cells with traditional canonical NF-κB pathway agonists (for example, TNF and lipopolysaccharide (LPS)) induced SIX1 and SIX2 through a mechanism that required signalling crosstalk with NIK 15 (Extended Data Fig. 3b -e). These data indicate that NIK induces the expression of SIX proteins under a variety of inflammatory conditions.
We noted that recombinant SIX1 and SIX2 proteins were expressed at unusually low levels when driven by a strong cytomegalovirus (CMV) promoter in HEK293 cells (Extended Data Fig. 3f, g ). Co-transfection of NIK or long-lasting treatment of cells with non-canonical NF-κB agonists induced CMV-driven expression of SIX proteins, revealing a post-transcriptional mechanism of control (Extended Data Fig. 3f-h) . Application of the 26S proteasome inhibitor MG132 also induced rapid accumulation of CMV-driven SIX proteins in HEK293 cells and endogenous SIX proteins in BMDMs and human fibroblasts, suggesting that these proteins are constitutively marked for ubiquitinmediated degradation 16 (Extended Data Fig. 3i-k) . Detailed kinetic analysis of endogenous SIX1 and SIX2 protein expression during noncanonical NF-κB pathway activation (Extended Data Fig. 3l ) and investigation of the ubiquitination status of SIX2 (Extended Data Fig. 3m ) revealed a concerted mechanism of SIX protein reactivation, involving the induction of SIX gene expression through secondary transcription followed by stabilization of SIX proteins through NIK-dependent inhibition of the ubiquitin-proteasome pathway (Extended Data Fig. 3n ).
SIX family members regulate gene expression programs during development 17 . However, mutations that prevent the assembly of transcriptional co-activator complexes had no bearing on the immunological activity of SIX2, implying that it has an alternative mechanism of action 18 (Extended Data Fig. 4a ). We found that SIX proteins 
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suppressed NIK-mediated immunity, suggesting that they may negatively regulate non-canonical NF-κB (Extended Data Fig. 4b-f) . We used whole-genome RNA sequencing (RNA-seq) to test this hypothesis. Chronic activation of non-canonical NF-κB by ectopic expression of NIK in fibroblasts induced the transcription of 891 genes, including those with primary and secondary inflammatory response signatures (Extended Data Fig. 4g , h, Supplementary Table 3) . Remarkably, nearly 30% of these genes were potently suppressed by co-transduction of SIX2, including cytokines and chemokines that harbour consensus κB transcriptional binding sites or that are indirectly stimulated by NF-κB (Extended Data Fig. 4i ). We confirmed that IL1B, IL8, IL13, IL33, CCL3, CCL19, CXCL1, and CXCL2 were inhibited by SIX2 using quantitative PCR with reverse transcription (qRT-PCR) (Extended Data Fig. 4j ). In addition, SIX1 −/− SIX2 −/− fibroblasts exhibited enhanced transcription of these genes after long-term cytokine stimulation (Fig. 2f ) or viral transduction of NIK (Fig. 2g) , indicating that endogenous SIX proteins negatively regulate inflammatory gene expression programs.
A subset of the SIX-regulated genes was induced by the canonical NF-κB subunit RELA (for example, IL1B and IL8) and others required non-canonical RELB (for example, IL13, IL33, CCL3, CCL19, CXCL1, and CXCL2) 2 (Extended Data Fig. 5a -c). To determine whether SIX proteins inhibit multiple NF-κB isoforms, as these data suggest, we analysed luciferase reporter expression driven by five NF-κB binding sites (5 × κB). Transient transfection of fibroblasts and HEK293 cells with SIX family members inhibited the stimulation of 5 × κB-LUC by long-term cellular application of the canonical and non-canonical NF-κB agonists TNF and LTα1β2, respectively (Extended Data Fig. 5d, e) . The potency of SIX2 was equivalent to those of well-known inhibitors of NF-κB, including IκB super repressor and A20, and was greater than either WIP1 or PIAS1 [19] [20] [21] [22] (Extended Data Fig. 5f ). Direct studies on RELA −/− and RELB
−/−
fibroblasts confirmed that the SIX proteins suppressed transcription by both the canonical and non-canonical NF-κB isoforms (Extended Data Fig. 5g ). Thus, SIX1 and SIX2 are negative regulatory components of the non-canonical NF-κB pathway by virtue of their NIKdependent expression, and not by differential recognition of RELA or RELB target genes. Mechanistic investigations suggested that SIX proteins exhibit gene-proximal inhibitory activities (Extended Data Fig. 6a-c) . SIX1 bound promoter regions neighbouring the κB sequence(s) of the IL1B, IL8, and CCL3 genes, indicating that it was primed for transcriptional inhibition (Fig. 3a, Extended Data Fig. 6d , e). Cytokine treatment induced further recruitment of SIX1 to these genes (Fig. 3a , Extended Data Fig. 6d) . Notably, the ability of SIX1 to occupy the promoters of inflammatory genes under both quiescent and stimulated conditions explains the observed increase in IL1B, IL8, and CCL3 mRNA expression in SIX1
SIX2
−/− cells (Fig. 2f) . SIX proteins formed a stable complex with nuclear RELA and RELB (Fig. 3b) . Notably, this interaction did not affect the recruitment of NF-κB to target gene promoters (Extended Data Fig. 6f ). In addition, SIX2 inhibited activation by both GAL4-RELA and GAL4-RELB of a 5 × GAL4 luciferase reporter gene, a reconstituted system that measures NF-κB transcriptional activity independent of its DNA binding preference 23 ( Fig. 3c, Extended Data Fig. 6g ). These data suggest that SIX proteins inhibit the trans-activation function of NF-κB. In support of this conclusion, SIX2 interacted directly with the trans-activation domain (TAD; residues 473-522) of RELA, the functional region of NF-κB that recruits chromatin remodelling enzymes and basal transcriptional machinery, including RNA Pol II 24 ( Fig. 3d) . Knockout of SIX1 and SIX2 increased the occupancy of IL1B and IL8 by RNA Pol II in both basal and cytokine-treated fibroblasts (Fig. 3e) . Collectively, these data support an inhibitory model in which SIX proteins regulate the trans-activation function of NF-κB at inflammatory gene promoters in a negative feedback loop (Extended Data Fig. 6h) .
We next sought evidence that SIX proteins suppress inflammatory gene expression programs in vivo. Knockout of Six1 or Six2 causes embryonic lethality in mice 10 . We therefore adapted a doxycyclineinducible system for broad tissue expression of a human SIX1 transgene in adult mice 25 (Extended Data Fig. 7a-d) . As doxycycline is a powerful antibiotic, we monitored the inflammatory response and progression of disease in mice exposed to bacterial LPS. SIX1 suppressed the LPS-induced transcription of inflammatory mediators in peritoneal macrophages ex vivo, indicating that the human transgene maintains its function across species (Extended Data Fig. 7e) . Remarkably, expression of SIX1 provided nearly complete protection of mice from a lethal LPS challenge as compared to littermate controls (Fig. 4a, Extended Data Fig. 7f ). Whereas the clinical signs of septic shock were indistinguishable between genotypes six hours after LPS injection, SIX1-expressing mice made a near-complete recovery over the time course of the experiment (Fig. 4b) . This recovery correlated with a reduction in inflammatory mediators in the serum of SIX1-expressing mice (Fig. 4c) . Although these findings clearly indicate that SIX proteins promote inflammatory resolution in vivo, we suspect that reactivation of SIX1 or SIX2 will have cell-type-specific functions under physiological conditions associated with non-canonical NF-κB activation. 
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We then searched for a second line of evidence that SIX proteins regulate biological systems associated with non-canonical NF-κB function. Previous studies indicate that combinatorial application of SMAC-mimetic compounds (for example, BV6) and TNF promotes death of cancer cells, including non-small-cell lung cancer (NSCLC), through non-canonical NF-κB activation 13, 14, [26] [27] [28] . However, many NSCLCs are resistant to death induced by BV6 and TNF, an observation that has limited the therapeutic efficacy of these compounds 27, 29, 30 . A potential mechanistic explanation for the resistance of cancer cells to SMAC-mimetics emerged from our studies on SIX proteins. Specifically, we identified three RAS and P53-driven NSCLC cell lines (H1155, H1792 and H2087) that were refractory to combined BV6-TNF-induced cell death and exhibited high levels of endogenous SIX1 and SIX2 (Fig. 4d, e) . CRISPR-Cas9-mediated knockout of SIX1 and SIX2 markedly sensitized these NSCLCs to BV6-TNF treatment (Fig. 4d, e) . The anti-apoptotic function of SIX proteins was also observed in SV40-immortalized fibroblasts and U-2 OS cells (Extended Data Figs. 8, 9a-g ). We confirmed that SIX1 and SIX2 suppressed caspase-8 mediated cell death in these cell lines (Extended Data Fig. 9h-j) .
To broadly investigate whether the protective effects of SIX proteins arise from regulation of gene expression programs, we treated wild-type and SIX1 −/− SIX2 −/− H1792 NSCLC cells with BV6 and TNF and processed them for RNA-seq. More than 90% of the analysed transcripts were unaltered by BV6-TNF treatment. However, of the 1,024 genes that were induced greater than twofold (false discovery rate (FDR) < 0.05) by BV6-TNF treatment in wild-type cells, 120 were substantially upregulated in SIX1 −/− SIX2 −/− cells (cluster I, Fig. 4f, Extended Data Fig. 10a, Supplementary Table 4 ). Cluster I genes had a strong inflammatory response signature with enrichment of transcripts from cytokines and chemokines with experimentally verified κB-binding sites (Extended Data Fig. 10b) . A large percentage of cluster I genes were also upregulated in unstimulated SIX1 Tables 5,  6 ). Together, these data provide an unbiased confirmation that SIX1 and SIX2 regulate gene-specific transcriptional responses induced by non-canonical NF-κB under both physiological and pathological conditions.
In summary, we have established that SIX family transcription factors function as immunological gatekeepers, dampening the promoter activity of inflammatory genes in response to persistent activation of the non-canonical NF-κB signalling cascade. In support of this mechanism, reactivation of SIX1 and SIX2 in immune cells is coupled to accumulation of NIK protein caused by chronic cytokine stimulation or pathogen infection. In addition, expression of SIX1 and SIX2 directly inhibits the trans-activation function of RELA and RELB in a negative feedback loop (Extended Data Fig. 6h ). These findings not only connect the non-canonical NF-κB signalling cascade to a mechanism of transcriptional repression, but also indicate that disruption of this response circuit may have important consequences for the pathogenesis of human disease, including cancer 1, 4, 5 .
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Data reporting.
No statistical methods were used to predetermine sample size. The experiments were not randomized and investigators were not blinded to allocation during experiments and outcome assessment unless otherwise stated. Plasmids and reagents. Flag-tagged constructs were generated by cloning the indicated genes into NotI and SalI sites of pCMV-6b-Flag backbone using Gibson Assembly Master Mix (E2611, NEB). RELA and RELB were cloned into BamHI and NotI sites of pEBB-HA. GFP-tagged constructs were assembled by cloning the indicated genes into EcoRI and BamHI sites of pEGFP-C2. NIK-stimulated genes and other indicated genes were cloned into the TRIP. CMV.IVSβ.GENE.ires.TagRFP destination vector 31 using Gateway LR Clonase II (11791, Invitrogen). The pRK5-HA-Ub plasmid was a gift from T. Dawson (17608, Addgene). GAL4-RelA and GAL4-LUC plasmids 23 were provided by E. Olson (UT Southwestern Medical Center). GAL4-RELB was assembled by cloning full-length RELB into EcoRI and XbaI sites using Gibson. NF-κB luciferase plasmid, containing 5 units of κB enhancer elements, was obtained from Agilent technology (219077). NIK kinase dead (K429/430A) 32 and IκB SR (S32/36A) 19 mutants were generated by mutagenesis of indicated amino acids. All gene cloning was verified by sequencing.
Recombinant TNF (210-TA, R&D), LTα1β2 (L5162, Sigma) and TWEAK (SRP4360, Sigma) were reconstituted in sterilized PBS containing 0.1% BSA. LPS (L2880, Sigma) was reconstituted in sterilized double-distilled H 2 O. Doxycycline (D9891) was purchased from Sigma. BV6 (B4653, Apexbio), Z-VAD (FMK007, R&D), and Z-IETD (ALX-260-020-M001, Enzo) were dissolved in DMSO. X-tremeGENE9 transfection reagent was purchased from Roche. 25 and then intercrossed with the CAG-rtTA3 line (016532, Jackson laboratory) to obtain rtTA3 +/− and rtTA3
Age-and gender-matched littermates were used for further experiments (animal age information is described below, both males and females were used in the following studies). rtTA3 +/− or rtTA3 +/− SIX1 + mice (6-7 weeks old) were given 2 mg ml
doxycycline (Dox) water containing 10 g l −1 sucrose for 10 days (Dox water was refreshed every 3-4 days). Mice were then injected with the indicated dose of LPS through intraperitoneal route. For survival and recovery assays, mice were monitored according to approved animal protocols and the survival rate was recorded at the indicated time post LPS injection. Mice were given a clinical score and then euthanized at the end point of the experiment (96 h post injection). Clinical score was given blinded according to physical conditions induced by LPS including hunched posture, reduced mobility, ability to obtain food/water, and dehydration. The score range was 0-9 (0: mouse was indistinguishable from untreated control; 9: mouse exhibited extreme sickness classified as moribund and was euthanized as the humane end point of the experiment). To measure IL-1β and CXCL2 production, blood samples were collected and serum was isolated using 1.1 ml Z-Gel microtube (41.1378.005, Sarstedt) at 4 h post injection. Quantikine or Duoset ELISA kit was used to measure the production of IL-1β (MLB00C, R&D) and CXCL2 (DY452-005, R&D). Experiments were performed according to the manufacturer's instructions. The absorbance units were measured by FLUOstar OPTIMA (BMG LABTECH).
Peritoneal macrophages were isolated from rtTA3 +/− and rtTA3 +/− SIX1 + mice as described previously 34 . In brief, 6-7-week-old mice were euthanized by CO 2 . Sterilized cold PBS (7-8 ml) was injected into the cavity through the peritoneal wall. Cell suspension fluid was aspirated from the peritoneum and pelleted at 1,000g for 3 min. Cells were then seeded in poly-lysine-pretreated 12-well plates and cultured in Dulbecco's modified Eagle's medium (DMEM) in the presence or absence of 2 μg ml −1 doxycycline. After 24 h, adherent cells were used for LPS administration.
To obtain primary bone-marrow-derived macrophages (BMDMs), bone marrow cells were collected from 6-week-old wild-type C57BL/6NJ, Nik
+ mouse femurs and tibiae. Red cells were eliminated by applying 1 × RBC buffer (TNB-4300-L100, TONBO biosciences). Cells were then cultured and differentiated in DMEM supplemented with 10% FBS and 10% conditioned medium from L929 cell culture for 6-7 days. Differentiated primary BMDM cells (2 × 10 5 ) were seeded in 12-well plates for infection with L. monocytogenes, cytokine treatment, or LPS administration. All cells were grown at 37 °C in a 5% CO 2 incubator.
Cell lines. SV40-immortalized STAT1
−/− fibroblasts (referred to as fibroblasts and described as WT in certain places to distinguish parental cells from the indicated gene edited cell lines) were provided by J.-L. Casanova, Rockefeller University and were cultured in RPMI (Gibco) supplemented with 10% FBS and 1 × NEAA. HCT116 (ATCC), U-2 OS (ATCC), HEK293A (J. Dixon, University of California, San Diego) and HEK293T (P. Bieniasz, Aaron Diamond AIDS Research Center) cells were cultured in DMEM (Gibco) supplemented with 10% FBS (Gibco or Sigma) and 1 × NEAA (Gibco ) were provided by J. Minna (UT Southwestern Medical Center) and were cultured in RPMI supplemented with 10% FBS and 1 × NEAA. Indicated knockout or stable cell lines were generated as described below. Common cell lines were identified by morphological features. Specific cell lines used in this study were authenticated by PCR or mutational status. All cells were mycoplasma negative and were grown at 37 °C in a 5% CO 2 incubator. Lentivirus production and transduction. For lentivirus production, 4 × 10 5 HEK293T cells were seeded in each well of polylysine-coated 6-well plates. One microgram of indicated lentivirus-expressing genes, 0.8 μg HIV gag-pol, and 0.2 μg vesicular stomatitis virus glycoprotein (VSV-G) were transfected into HEK293T cells by X-tremeGENE 9. The transfection medium was replaced with fresh DMEM/3% FBS/1 × NEAA after 6 h. Lentiviral particles were collected at 48 h and 72 h. Pooled supernatants were cleared by centrifugation at 1,500 r.p.m. for 5 min. Supernatants, supplied with 20 mM HEPES and 4 μg ml −1 polybrene, were stored at −80 °C.
For lentivirus transduction, 7 × 10 4 fibroblasts, HEK293A or U-2 OS cells were seeded into each well of 24-well plates. Cells were transduced with the indicated lentivirus in transduction medium (RPMI or DMEM supplemented with 3% FBS, 20 mM HEPES and 4 μg ml −1 polybrene) by spinning at 1,000g for 45 min at 37 °C. The transduction medium was replaced with culture medium after 6 h. Transduced cells were split into duplicate after 48 h transduction, followed by bacteria and virus infection assays. Bacteria and virus infection. To generate GFP-expressing Shigella, S. flexneri M90T was transformed with a pBBRMCS1-GFP plasmid. GFP-expressing L. monocytogenes (10403s strain) was a gift from D. Portnoy (University of California, Berkeley). For Shigella infection, bacteria were grown in BHI broth medium (237500, BD Science) supplemented with 5 μg ml −1 chloramphenicol (CAM) at 30 °C with 200 r.p.m. shaking overnight. Bacteria were then diluted 1:25 into BHI with 5 μg ml −1 CAM and incubated at 37 °C for about 2 h (OD 600 = ~0.5). Bacteria were washed with PBS and then suspended in PBS/0.03% Congo red (C6277, Sigma) and incubated at 37 °C for 15 min. Bacterial suspensions (MOI of 10:1) were inoculated into each well of 24-well-plates, followed by centrifugation at 1,000g for 10 min. Infected cells were then incubated at 37 °C in a 5% CO 2 incubator for 1.5 h. Extracellular bacteria were killed by replacing the medium with medium supplemented with 50 μg ml −1 gentamicin. After 8 h incubation, cells were collected for flow cytometry analysis. For Listeria infection, bacteria were cultured overnight in BHI at 30 °C without shaking and suspensions (MOI of 10:1) were inoculated into each well of 24-well-plates (for U-2 OS cells, centrifugation at 1,000g for 7 min was performed to help Listeria adhesion) and incubated for 1.5 h. Cells were then incubated for 4.5 h after replacing the medium with gentamicin-containing medium.
Viral infection was performed as previous described 9 . In brief, all viruses were suspended in RPMI medium supplemented with 1% FBS and 1 × NEAA. Cells were infected by adding 200 μl viral suspension to each well of 24-well-plates (MOI of 0.5:1) and then incubated after adding 800 μl RPMI medium supplemented with 10% FBS and 1 × NEAA for the indicated time periods: EAV (19 h, 1 h infection + 18 h incubation), WINV (25 h, 1 + 24), PIV3 (16 h, 3 + 13), and SINV (10 h, 1 + 9). Flow cytometry and data analysis. To quantify bacterial and viral infection efficiency, infected cells were detached using Accumax warmed to 37 °C (Sigma), followed by centrifugation at 800g for 2 min. Cells were then fixed by suspending in PBS/1% PFA at 4 °C for at least 30 min. Cells were then stored in PBS/3% FBS. Stratedigm S1000 flow cytometry was used to distinguish RFP-, BFP-, and GFP-expressing cells. All flow cytometry generated raw data were analysed using Letter reSeArCH FlowJo 10.0.6. For most analyses, we gated live cells, single cell populations from live cells, and then RFP-positive cells from the single-cell population. Finally, we gated GFP-positive units from the RFP-positive population. For RFP-, BFP-, or GFP-expressing experiments, we gated cells that expressed both RFP and BFP to analyse the GFP-expressing population. CRISPR-Cas9 gene editing cell lines. RELA, RELB, NIK, TAK1, or SIX1/SIX2 guide RNA (the guide targets both SIX1 and SIX2 genes) was cloned into lenti-CRISPR v2 vector 35 (F. Zhang, Addgene 52961) according to the manufacturer's protocol. Lentivirus was produced as described above. We transduced 7 × 10 4 fibroblasts or U-2 OS, H1155, H1792, or H2087 cells with the indicated lentivirus and incubated them for 48 h. Transduced cells were then selected with 2 μg ml −1 (fibroblasts and U-2 OS) or 5 μg ml −1 (H1155, H1792, and H2087) puromycin for 7 days. Single colony cells were sorted by flow cytometry. Homozygote knockout cells were then identified by genotyping and western blot. Knock out of SIX1 and SIX2 in H1155, H1792, and H2087 cells resulted from a single T insertion to both alleles (Extended Data Fig. 4c 
To analyse RELA and RELB translocation, the cell plasma membrane was disrupted by incubation in lysis buffer (50 mM Tris-HCl pH7.6, 150 mM NaCl, 1% NP-40, and 1 × protease inhibitor cocktail). Nuclei were pelleted by centrifugation and cytosolic extracts were collected for analysis. Nuclei were then washed 2-3 times with lysis buffer and were boiled in lysis buffer to obtain nuclear extracts. 12% SDS-PAGE was used to separate H3.
For BV6-or MG132-induced accumulation of CMV-Flag-SIX2, indicated plasmids were transfected into 5 × 10 4 HEK293T cells. After 24 h transfection, cells were treated with 5 μM BV6 or 30 μM MG132 for 24 or 12 h. For NIK-induced accumulation of SIX1 and SIX2, GFP-SIX1 and GFP-SIX2 were co-transfected with Flag-NIK into HEK293T cells. SIX1 and SIX2 expression was quantified by fluorescence microscopy and western blot after 48 h transfection. To test BV6-TNF-induced activation of the apoptosis pathway, 1 × 10 5 fibroblasts were seeded in 12-well plates. Cells were then treated with 25 ng ml −1 TNF plus 2.5 μM BV6 with or without 30 μM z-VAD or 40 μM z-IETD for 6 h. 12% SDS-PAGE was used to separate cleaved caspase-3. Immunoprecipitation assay. To test the interaction between SIX2 and RELA/ RELB, 8 × 10 5 HEK293T cells were transfected with the indicated plasmids (6 μg total). After 48 h, cells were lysed in 1 ml lysis buffer, followed by 30 s on and 30 s off sonication for 7-10 cycles to break the nuclei. Anti-Flag immunoprecipitation was carried out using anti-Flag M2 affinity gel (A2220, Sigma) for 4 h. Beads were then washed four times with lysis buffer. Co-immunoprecipitated proteins were separated by SDS-PAGE and the proteins were detected by anti-HA or anti-Flag western blot.
For ubiquitination of SIX2, Flag-SIX2 and HA-Ub were co-transfected with empty vector or GFP-NIK into HEK293T cells. After 48 h, equal amounts of Flag-SIX2 proteins were loaded for anti-Flag immunoprecipitation. Ubiquitinated SIX2 was detected by anti-HA western blot. Yeast two-hybrid assay. To test the interaction between SIX2 and the RELA trans-activation domain, full-length SIX2 was cloned into the pACT2-AD vector (GAL4 activation domain (AD)). Amino acids 473-522 of RELA, which does not have the capacity to self-activate 36 , was cloned into pLexNA-BD vector (GAL4 DNA binding domain (BD)). Yeast transformation was performed using the standard LiAc-based method. Equal amounts of indicated yeast cells were placed on either minimal synthetic defined (SD) bases (Clontech) supplied with yeast synthetic drop-out media supplements that without uracil, leucine, and tryptophan (SD/UWL − , Clontech) or supplied with yeast synthetic dropout media supplements that without tryptophan, histidine, uracil, leucine, and lysine (SD/WHULK − , Clontech) with 10 μM 3-amino triazole (3-AT) and grown for 2-3 days. RNA sequencing and data analysis. RNA-seq was performed at UTSW McDermott Center Next Generation Sequencing Core and analysed at the McDermott Center Bioinformatics Laboratory as described previously 37 . In brief, Fluc or NIK lentivirus was transduced into fibroblasts. After 72 h, total RNA was purified according to the RNeasy Mini Kit instructions (QIAGEN, 74104) and prepared according to the TruSeq stranded mRNA sample preparation guide (Illumina). Sequencing data were then generated using an Illumina HiSeq 2500 by reading paired-end 100-bp (base pair) reads. To consider the NIK-stimulated genes, each read was mapped to the human genome based on Human-hg19 by Tophat (v2.0.10) based on igenome annotations (https://ccb.jhu.edu/software/ tophat/igenomes.shtml). Cufflinks/Cuffdiff (v2.1.1) was then used to calculate the expression value of each sample and to identify differentially expressed genes in the Fluc or NIK sample using a regularized t-test 38 . Only genes with log 2 (fold change; FC) ≥1 or ≤−1 and false discovery rate (FDR)< 0.05 were considered as up-or downregulated by NIK compared to Fluc control.
To 
SIX2
−/− cells were mock-treated or treated with 5 μM BV6 and 25 ng ml −1 TNF for 24 h. The total RNA was extracted from the adherent cells. RNA-seq was performed as described above. The read length for this experiment was 75 bp single-end. To analyse the differential expression profiles, fastq files were checked for quality using fastqc (v0.11.2; http://www.bioinformatics. babraham.ac.uk/projects/fastqc) and fastq_screen (v0.4.4; http://www.bioinformatics.babraham.ac.uk/projects/fastq_screen) and were then quality trimmed using fastq-mcf (ea-utils/1.1.2-806) 39 . Trimmed fastq files were mapped to hg19 (UCSC version from igenomes) using TopHat 40 , duplicates were marked using picardtools (v1.127 https://broadinstitute.github.io/picard/), read counts were generated using featureCounts 41 and differential expression analysis was performed using the generalized linear model likelihood ratio test implemented in edgeR 42 . For comparison of BV6-TNF-induced genes in wild-type cells, only genes that exhibited log 2 (counts per million) ≥ 0.1, log 2 (FC) ≥ 1, and FDR < 0.05 were considered upregulated. Genes that were differentially regulated between BV6-TNF-treated wild-type and SIX1
−/−
SIX2
−/− cells were identifed by log 2 FC ≥ 1 (up) or ≤ −1 (down) and FDR < 0.05. The remaining genes were considered as no change. The expression levels of each of the 1,024 differentially expressed genes were normalized across conditions to generate z-scores and presented in Fig. 4f . Final gene lists were then used for pathway analysis with QIAGEN's Ingenuity Pathway Analysis tool (QIAGEN Redwood City, http://www.qiagen.com/ingenuity). Trends in these gene lists were also plotted using various R packages (https://www.R-project.org/). The significance values for the canonical pathways were calculated using one-sided Fisher's exact test. RNA-seq data validation and qRT-PCR. To validate RNA-seq data, experiments were performed as described above. In brief, total RNA was isolated for synthesizing cDNA using SuperScriptIII First-Strand Kit (18080051, Invitrogen). The gene expression level was quantified using real-time PCR by detecting the SYBR green (4309155, ABI) with an ABI 7500 fast real-time PCR system. To test whether SIX1 and SIX2 suppressed NIK-stimulated genes and whether these NIK-stimulated genes were dependent on RELA or RELB, wild-type, TWEAK for 24 h. For LPS-induced expression of inflammatory mediator genes in peritoneal macrophages, cells were treated with 100 ng ml −1 LPS for 4 h. Relative gene expression was adjusted to that of the housekeeping gene Actb (mouse or human) and then normalized to experimental controls. NIK-stimulated genes library. On the basis of RNA-seq data, we identified 273 genes as NIK-stimulated. Of these, 237 genes were cloned into the TRIP.CMV. IVSβ.GENE.ires.TagRFP destination vector. We obtained 141 genes from the hORF Collection (Invitrogen), 35 from DNASU 43 and 61 from the type I interferon library 31 . Lentiviruses were produced as described above. TNF or 50 ng ml −1 LTα1β2 for 24 h. Luciferase activity was measured according to the manufacturer's protocol (E1500, Promega). ONPG buffer (2-nitrophenyl β-d-galactopyranoside dissolved in 200 mM NaH 2 PO 4 , 2 mM MgCl 2 , and 100 mM β-mercaptoethanol) was used to measure LacZ activity. The luminescence and absorbance units were measured using FLUOstar OPTIMA (BMG LABTECH).
Letter reSeArCH
Relative luciferase activity was quantified by adjusting to LacZ control and normalizing to experimental control. Fluorescence microscopy. To analyse the localization of truncated SIX2 fragments, 2 × 10 4 U-2 OS cells were seeded onto coverslips in 24-well plates. Indicated Flagtagged SIX2 fragments were transfected into cells. After 48 h, cells were washed 2-3 times with PBS and were fixed by incubation in 500 μl PBS/3.7% formaldehyde for 10 min at 37 °C, followed by washing three times with PBS and incubation in 500 μl PBS/50 mM NH 4 Cl for 10 min. Cells were permeabilized in PBS/10% horse serum/0.5% Triton X-100 for 45 min. Cells were then incubated with primary antibodies (1:500 anti-Flag in PBS/10% horse serum/0.5% Triton X-100) for 45 min. After washing three times with PBS, secondary antibody (1:500 fluoresceinconjugated goat anti-mouse from Pierce and 1:1,000 DAPI in PBS/10% horse serum/0.5% Triton X-100) was added and incubated for 45 min. After washing three times with PBS and once with H 2 O, the samples were mounted on slides and images were processed using a Zeiss Observer Z1 fluorescent microscope. ChIP. A GFP-SIX1 stable cell line was generated by cloning GFP-SIX1 into a pSCRPSY-blasticidin backbone. Lentiviruses were produced as described above. Fibroblasts and HCT116 cells were transduced and selected using 10 μg ml −1 blasticidin. Positive cells were used for the following experiments. The ChIP assay was performed according to the manufacturer's instructions (Millipore, . In brief, 1.0 × 10 7 cells were cross-linked with 1% PFA for 10 min at 37 °C and 125 mM glycine was used to quench crosslinking. Cells were then washed with chilled PBS twice, and lysed in lysis buffer (5 mM PIPES pH 8.0, 85 mM KCl, 0.5% NP-40, 1 mM PMSF, 1 × protease inhibitor). The nuclei were then pelleted down by spinning at 3,000 r.p.m. for 5 min and were resuspended in RIPA buffer (50 mM Tris-HCl pH 8.0, 1% NP-40, 150 mM NaCl, 0.5% sodium deoxycholate, 0.1% SDS, 2.5 mM EDTA, 1 mM PMSF, 1 × protease inhibitor). Nuclei lysates were sonicated for 40 cycles (HCT116 cells, 70 cycles for fibroblasts) with 30 s on and 30 s off to yield fragments of 200-1,000 bp using Bioruptor (Diagenode). Six micrograms of IgG, SIX1, RELA or Pol II antibodies were conjugated with protein G beads (10004D, Invitrogen) for 1 h and blocked using 5% BSA for 1 h. After spinning down sonicated nuclei lysates at 13,000 r.p.m. for 10 min, we incubated an equal volume of supernatant of sonication products with the pre-conjugated protein G beads at 4 °C overnight. The bound beads were washed with RIPA buffer, low salt buffer, high salt buffer, and LiCl buffer once, and finally with TE buffer twice. The bound protein-DNA complex was eluted using 500 μl elution buffer (100 mM NaHCO 3 , 1% SDS). We added 20 μl 5 M NaCl to reverse crosslinks of protein and DNA by heating at 65 °C for over 4 h or overnight. DNA was recovered by PCA and precipitated using ethanol in the presence of glycogen (AM9515, Invitrogen). Enrichment at the IL1B, IL8, and CCL3 promoters was measured by quantitative PCR (qPCR). Fold enrichment was normalized to experimental control. For RELA and Pol II ChIP experiments, fold enrichment was adjusted to 'input DNA' that was saved before immunoprecipitation and then normalized to experimental control. Cell viability assay. The indicated cells (5 × 10 3 for 48 h treatment or 1 × 10 4 for 24 h treatment) were seeded into 96-well plates (Costar, black with clear flat bottom, 3603). After 19 h, the medium was removed and fresh medium supplemented with the indicated compounds was added and incubated at 37 °C with 5% CO 2 for 24 or 48 h. Whole-cell ATP levels were measured using CellTitre Glo following the manufacturer's instructions (G7572, Promega). The luminescence units were measured using FLUOstar OPTIMA (BMG LABTECH R has a silent mutation in the gRNA recognition sequence of the SIX2 cDNA that cannot be targeted by CRISPR-Cas9). After 50 h, transduced cells were seeded in 96-well plates and the experiments were performed as described above. Reporting summary. Further information on research design is available in the Nature Research Reporting Summary linked to this paper.
Data availability
All data generated during this study that support the findings are included in the manuscript or in its Source Data and Supplementary Information. All materials are available from authors upon reasonable request. The RNA-seq data associated with Fig. 4f Fig. 1c . Fluc-and NIK-transduced cells were lysed and probed with anti-NIK antibody. j, Previous studies have suggested that ectopic expression of NIK is cytotoxic in A549 cells 44 . To test whether ectopic expression of NIK is cytotoxic in fibroblasts, we transduced fibroblasts with indicated lentivirus and measured cell viability after 72 h by measuring ATP. Data are mean ± s.d. from six independent experiments. P values were measured using one-way ANOVA (GraphPad); ***P < 0.001, ****P < 0.0001; ns, no significant difference. The same statistics were used in later figures unless otherwise stated. Western blot data are representative of three independent experiments. For gel source data, see Supplementary Fig. 1 . Fig. 2 | Library screen for NIK-stimulated genes. a, Schematic of NIK-stimulated gene library design, cloning, and multidimensional flow cytometry-based high-throughput screen. NIKstimulated genes were identified by RNA-seq. The cDNAs of 237 NIKstimulated genes were individually cloned into the lentiviral vector pTRIP upstream of IRES-tagRFP (see Methods). Fibroblasts were transduced with lentivirus in a one-gene to one-well format and were then infected with GFP-expressing pathogens, including Lm, Sf, EAV, WNV, SINV, or PIV3 in independent experiments. The effect of a single gene expression on infection was quantified by flow cytometry. b, Relative expression levels of NIK-stimulated genes identified by RNA-seq. Fluc or NIK lentivirus was transduced into fibroblasts. Total RNA was isolated after 72 h and gene expression was determined by RNA sequencing. Graph shows expression of genes that were significantly stimulated (red, 237 genes) or downregulated (green, 84 genes) by NIK expression compared to Fluc control. Fold change of more than 2 (log 2 ≥ 1) or less than 0.5 (log 2 ≤ −1) and FDR < 0.05 (see Methods). Bars were ranked numerically from low to high (see Supplementary Table 1 ). The expression levels of SIX1 and SIX2 are indicated. Data are representative of two independent experiments. c, Efficiency of lentiviral expression of NIK-stimulated genes used in the high-throughput bacterial and viral screen. NIK-stimulated genes were transduced into fibroblasts in a 'one-gene to one-well' format. Transduction efficiency measured as per cent RFP + cells was determined by flow cytometry and was ranked numerically from low to high (see Source Data, values are the average of two technical replicates). Twelve out of 237 genes were poorly transduced (less than 20% RFP + ) and were excluded from subsequent analyses. d, Dot plots of S. flexneri, L. monocytogenes, EAV, WNV, SINV, and PIV3 infectivity in the presence of expressed NIK-stimulated genes (in c). Data were normalized to the average of each screen, indicated as the black dotted line. We chose to confirm hits in Fig. 1d on the basis of two criteria: (1) the effect of gene expression on inhibiting or enhancing pathogen infection by less than or greater than 50%; and (2) an adjusted z-score less than −2 or greater than 2 (see Supplementary Table 2) . NIK-stimulated genes that reproducibly and significantly inhibited (green) or enhanced infection (red) by these criteria are indicated. The genes shown in black font are hits that were not reproduced in the confirmatory experiments (Fig. 1d) . Data are mean ± s. 17 and that SIX1 residues C16 and V17 are required for this interaction 18 . These residues are conserved in SIX2. We used mutant SIX2(C16RV17E) to show that SIX2 enhances L. monocytogenes infection independent of EYA interaction. . RFP-, BFP-and GFPexpressing cells were gated by flow cytometry. Infection was quantified as in Extended Data Fig. 1h . Data are mean ± s.d. from six independent experiments. ***P < 0.001, ****P < 0.0001; ns, no significant difference. −/− SIX2 −/− (NIK). Relative infectivity was normalized to WT (Fluc) control. These data indicate that SIX proteins oppose the function of NIK, potentially through suppression of non-canonical NF-κB gene expression (see f). Data are presented as mean ± s.d. from six independent experiments. ****P < 0.0001; ns: no significant difference. f, Relationship between NIK expression, SIX protein accumulation, and antimicrobial immunity. g, RNA-seq experiments used to identify NIK-stimulated genes that are suppressed by SIX2. Table 3 ). h, Group comparisons from data generated in g. In brief, NIK-stimulated genes that are suppressed by SIX2 were determined by comparing Group IV with Group II (log 2 ≤ −1) and then adjusted to NIK-stimulated genes from comparison of Group II with Group I (fold change > 4), FDR < 0.01 (see Methods). i, Representative raw data from RNA-seq experiments in g, h presented as fragments per kilobase of transcript per million mapped reads (FPKM) (bars show mean from two independent experiments indicated as circles). j, Validation of RNA-seq data. Experiments were performed as in g. Gene transcription level was determined by qRT-PCR and relative gene expression was normalized to Fluc control. Data are mean ± s.d. of three or two technical replicates and representative of three independent experiments. For gel source data, see Supplementary Fig. 1 . −/− , and RELB −/− fibroblasts to stimulate the non-canonical NF-κB signalling pathway. mRNA expression of the indicated genes was evaluated by qRT-PCR. We conclude that IL1B is specifically stimulated by RELA because it is expressed in RELB −/− cells but not in RELA −/− cells. Similar logic was used to evaluate the seven additional genes shown. Experiments were performed as in Fig. 2g . Bars are means of two technical replicates (shown as circles) and representative of two independent experiments. d, The human SIX family consists of six unique isoforms. To determine which of these genes suppress NF-κB-mediated gene expression, empty vector (EV), SIX1, SIX3, SIX4, SIX5, or SIX6 cDNA was co-transfected with 5 × κB-LUC into HEK293T cells. After 24 h, cells were mock-treated or treated with 25 ng ml −1 TNF for 24 h. Luciferase activity was measured and normalized to EV untreated control. SIX1, SIX3, and SIX6 (SIX2 was not evaluated) inhibited both basal and inducible activity of NF-κB. Data are mean ± s.d. from seven independent experiments. e, SIX2 inhibits LTα1β2-and TNF-induced NF-κB activation. EV or Flag-SIX2 was co-transfected with 5 × κB-LUC into fibroblasts. After 24 h, cells were mock-treated or treated with 25 ng ml −1 TNF or 50 ng ml H1792 cells were treated with mock or 50 ng ml −1 TWEAK for 24 h. Cell lysates from cytoplasmic or nuclear fractions were analysed by western blot. Neither SIX1 nor SIX2 blocked RELA phosphorylation or p100/52 processing, or restricted NF-κB translocation to the nucleus. b, Top, SIX proteins are composed of a SIX domain (SD), homeobox domain (HD), and coiled-coil (CD) region. Full-length SIX1 and SIX2 have 80% identical amino acids over the protein-coding sequence. The SD and HD domains (residues 1-183) are 96% identical 46 . The indicated Flag-tagged SIX2 fragments were transfected alone into U-2 OS cells and processed for microscopy (middle, scale bars represent 20 μm) or transfected with 5 × κB-LUC into HEK293T cells and processed for κB reporter activity (bottom). The highly conserved SD-HD domain was the minimal fragment that inhibited κB reporter activity. This fragment strictly localized to the nucleus, indicating that SIX proteins inhibit nuclear activity of NF-κB. Graph data analysed as in Extended Data Fig. 5d . Data are mean ± s.d. from nine independent experiments. c, SIX2 inhibits gene activation from the IL8 promoter. pIL8-LUC plasmid composed of the 1.5-kb promoter region of IL8 cloned upstream of LUC was co-transfected with indicated plasmids into HEK293T cells. After 24 h, cells were mock-treated or treated with 25 ng ml −1 TNF for 24 h. Luciferase activity was then measured and analysed as in Extended Data Fig. 5d . Data are mean ± s.d. from nine independent experiments. These data suggest that SIX proteins inhibit NF-κB activation at gene promoters. d, ChIP experiment providing additional evidence that SIX proteins bind to inflammatory gene promoters (Fig. 3a) . Chromatin was prepared from stable GFP-SIX1 cell lines (HCT116 cells), mock-treated or treated with 25 ng ml −1 TNF for 2 h. Anti-SIX1 antibodies (or anti-IgG control) were used to immunoprecipitate SIX1 from nuclear extracts. Co-eluted DNA was amplified using primer sets as in Fig. 3a . Relative promoter occupancy was normalized to each experimental IgG control. Bars are means of two technical replicates (shown as circles) and data are representative of three independent experiments. e, Control experiments corresponding to Fig. 3a and Extended Data Fig. 6f showing GFP-SIX1 expression. Wildtype and stable GFP-SIX1 fibroblasts were stimulated with 50 ng ml
Extended Data
TWEAK for 24 h. GFP-SIX1 expression was measured by western blot. f, SIX1 expression does not affect recruitment of RELA to the IL8 promoter. Chromatin was prepared from wild-type or GFP-SIX1 stable fibroblasts and immunopreciptated with anti-RELA. Bound DNA was amplified and quantified by qPCR. Results were adjusted to 'input DNA' that was saved before immunopreciptation. Relative enrichment was then normalized to each group's untreated control. Data are mean ± s.d. from three independent experiments. g, Control experiments corresponding to Fig. 3c showing that SIX2 inhibits 5 × κB-LUC activity induced by GAL4-RELA and GAL4-RELB. GAL4 -RELA or GAL4-RELB construct was co-transfected with indicated plasmids into HEK293T cells. Fortyeight hours after transfection, the luminescence units were measured. Data are mean ± s. BV6-TNF induced NIK-dependent expression of both SIX1 and SIX2, suggesting that this cascade may be responsible for resistance to this treatment. e, f, We introduced a silent mutation in the gRNA recognition sequence of SIX2 cDNA that cannot be targeted by CRISPR-Cas9 (SIX2 R , e, top). Expression of SIX2 R in SIX1 −/− SIX2 −/− fibroblasts rescued the cell death phenotype (e) and suppressed both PARP and caspase-3 cleavage (f) induced by BV6-TNF. Wild-type and SIX1 −/− SIX2 −/− fibroblasts were transduced with Fluc or SIX2 R lentivirus. After 72 h, cells were mocktreated or treated with 0.2 μM BV6 plus 10 ng ml −1 TNF for 24 h. Cell viability was determined by measuring ATP. Cell survival was normalized to each untreated control (e, bottom). For western blot, cells were treated with 2.5 μM BV6 plus 25 ng ml −1 TNF for 6 h (f). All quantified data are mean ± s.d. from nine independent experiments. **P < 0.01, ****P < 0.0001. Western blot data are representative of three independent experiments. For gel source data, see Supplementary Fig. 1 .
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Data collection
Flow cytometry (Stratedigm, model:S1000) was used to collect infectivity data by sorting GFP-, RFP-, or BFP-expressed cells. Illumina HiSeq 2500 was used to generate RNA-seq data. qRT-PCR data were generated by ABI 7500 fast real-time PCR machine. Luciferase reporter, ELISA, and cell viability data were measured by FLUOstar OPTIMA (BMG labtech).
Data analysis
FlowJo 10.0.6 was used to analyze FACS data; Graphpad prism 7 was used to perform statistical analysis; Tophat (v2.0.10) was used to map the RNA-seq reads; Cufflinks/Cuffdiff (v2.1.1) was used to calculate the gene expression value; fastqc (v0.11.2) and fastq_screen (v0.4.4) were used to check the quality of RNA-seq reads; fastq-mcf (ea-utils/1.1.2-806) was used to trim quality of reads; picard-tools (v1.127) was used to mark the duplicates; featureCounts was used to count the reads; edgeR was used to distinguish the differential gene expression; Ingenuity Pathway Analysis tool was used to perform pathway analysis; various R packages was used to plot the pathway enrichment.
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All figures associated raw data of graphs and western blot gels were deposited in Source data and in Supplementary figure. All data or materials associated this study are available from authors upon reasonable request. RNA-seq data have been deposited to NCBI GEO. Accession number is GSE126535 nature research | reporting summary
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Sample size
Although no statistical methods were used to predetermined sample size in vitro and in vivo analyses, we conducted preliminary experiments to estimate variances in each assay and determined sufficient sample size. The biological sample size is presented in the figure or stated in the figure legends section.
Data exclusions No data were excluded from the analyses.
Replication
All attempts at replication were successful. The experiments number has been clearly stated in the figure legends.
Randomization No randomization was used in this study. For in vitro experiments, indicated genotype cells were transduced with indicated lenti-virus, transfected with indicated plasmids, or treated with indicated drugs. For in vivo mice experiments, mice were grouped according to the genotype.
Blinding
For in vitro experiments, no blinding was done. For clinical score analysis, survival mice were evaluated blindly to reach clinical score.
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Policy information about studies involving animals; ARRIVE guidelines recommended for reporting animal research Laboratory animals SIX1 transgene mice are FVB genetic background. CAG-rtTA3 mice are C57BL/6 background. rtTA3-SIX1 mice and their littermate controls (rtTA3) were obtained by intercrossing SIX1 mice with CAG-rtTA3 mice. 6-7 weeks old mice were given doxycycline water for 10 days prior to LPS administration experiments. Nik-/-mice are C57BL/6 background. 6-week-old mice were used for experiment. Both males and females were used for experiments.
Wild animals
The study did not involve wild animals.
Field-collected samples
The study did not involve samples collected from the field.
Ethics oversight
All animal experiments were performed according to the protocol that approved by UT Southwestern Medical Center IACUC.
Note that full information on the approval of the study protocol must also be provided in the manuscript.
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Methodology Sample preparation
We seeded indicated cells in the 24-well-plate. Cells were then transduced with indicated lentivirus and then challenged with the GFP-expressing bacterial or viral pathogens. Cells were then detached by 37°C warmed Accumax (Sigma), followed by centrifugation at 800×g for 2 minutes. Cells were then fixed by suspending in PBS/1% PFA at 4°C for at least 30 minutes. Cells were then stored in PBS/3% FBS. Tick this box to confirm that a figure exemplifying the gating strategy is provided in the Supplementary Information.
